Almondz Global Securities Limited Overview
Almondz Global Securities is a New Delhi-based diversified financial-services holding company that has turned into a three-legged conglomerate. The original legacy is a mid-tier Indian investment bank and broker founded in 1994, which still provides debt and equity capital-markets advisory, merchant banking, broking and wealth advisory. The largest revenue engine is now infrastructure consultancy, run through its 58.52%-owned subsidiary Almondz Global Infra-Consultant Limited (AGICL). AGICL supplies project-management, supervision and advisory services, mainly to government infrastructure agencies, and contributed about 64% of consolidated revenue in FY2026. The largest profit contributor is a 40.99% equity-accounted stake in Premier Green Innovations Private Limited (PGIPL), a grain-based fuel-ethanol producer with 485 KLPD of installed capacity in Himachal Pradesh and Odisha. PGIPL accounted for about 58% of consolidated net profit in FY2026. Management is now restructuring the group through a proposed demerger and separate listing of the infrastructure-advisory business.
What the company does
AGSL runs three economic verticals. Management names them in its Q1 FY2027 press release (28 July 2026):
-
Financial services. Wealth advisory and broking, corporate advisory and merchant banking, plus proprietary debt and equity market operations.
-
Green fuel. Production of grain-based ethanol and distillery operations through the joint venture/associate PGIPL. AGSL holds 40.99% and its parent Avonmore holds a further 8.88%.
-
Infrastructure advisory. Project-management consultancy, feasibility studies, design and supervision, and authority's/independent engineer roles, delivered through AGICL.
For statutory segment reporting under Ind AS 108, the consolidated accounts present six segments: (a) Debt and equity market operations; (b) Consultancy and advisory fees; (c) Wealth advisory / broking activities; (d) Finance activities; (e) Healthcare activities; (f) Others. The green-fuel business does not appear as a revenue segment. Because PGIPL is an associate, its contribution enters the income statement only as "share of profit of equity-accounted investees" (₹16.60 crore in FY2026).
The company's own description
The CARE rating rationale, drawing on company disclosures, describes AGSL as the flagship of the Almondz Group. Its activities are listed as corporate-finance advisory, investment banking, trading and investment in debt and equity securities, equity/commodity/fixed-income broking, distribution of financial products, wealth management and NBFC activities. Through subsidiaries and JVs it has also expanded into infrastructure consultancy (AGICL) and green-fuel manufacturing (PGIPL). Screener's summary of the annual report describes the group as delivering "360-degree" advice across infrastructure (highways, power, airports, urban and water), investment banking, institutional equities, research, broking, wealth management and depository services.
Revenue model
| Revenue type | Source | Character | FY2026 weight (consolidated revenue from operations ₹190.43 cr) |
|---|---|---|---|
| Fee and commission income: consultancy | AGICL infrastructure advisory contracts (milestone/time-based billing, about 80% from government and government-backed clients per CARE) | Service, contract-backed, multi-year | ₹154.72 cr in the "Consultancy & advisory fees" segment (about 81% of segment revenue; CARE puts infrastructure alone at about 64% of operating income) |
| Fee and commission income: capital markets | Arrangement fees on debt and equity issuance, merchant banking, M&A and corporate advisory | Transactional, cyclical | Included in the consultancy segment and not separately disclosed |
| Brokerage and distribution | Equity, commodity and debt broking; wealth and product distribution | Transactional / AUM-linked | ₹12.85 cr (Wealth advisory / broking segment) |
| Treasury / trading ("Others" line plus fair-value changes) | Proprietary debt and equity positions; gains on strategic stake sales | Mark-to-market, volatile | ₹22.21 cr segment revenue (Debt & equity market operations), offset by ₹16.89 cr of fair-value losses booked in expenses |
| Interest and dividend | Treasury and loan book | Recurring, small | ₹2.15 cr |
| Share of associate profit (below the line) | PGIPL ethanol | Equity-method income | ₹16.60 cr (not revenue) |
There is no product, subscription or licensing revenue. The group is a service and investment business. Manufacturing exposure is held only indirectly through the associate.
Value-chain position and customers
Infrastructure advisory: AGICL sits upstream of EPC contractors as an owner's-side consultant (project-management consultant, independent engineer, authority's engineer, detailed project report preparer). Its customers are central and state infrastructure agencies (roads, railways, urban, industrial-park development such as Odisha IDCO), multilateral-funded projects and private concessionaires.
Financial services: AGSL acts as an intermediary between issuers (corporates, PSUs, state entities raising debt) and investors (institutions, HNIs, retail). It is strongest in debt-capital-markets arrangement, a historical Almondz niche.
Green fuel: PGIPL is a midstream processor that converts grain (broken rice/maize) into fuel ethanol and sells it to oil marketing companies (OMCs: IOCL, BPCL, HPCL) under the Government of India's Ethanol Blended Petrol (EBP) Programme. Its by-products include DDGS. Sales are tender-allocated, with the price administered by the government.
Independent characterisation
On paper AGSL is a "securities" company, but economically it now operates as a holding company for an infrastructure consultancy and an ethanol producer, with a sub-scale broking and investment-banking franchise attached. FY2026 shows this clearly:
-
The legacy wealth/broking segment shrank from ₹20.29 cr to ₹12.85 cr in revenue.
-
Debt and equity market operations broke even only because a gain on the stake sale offset fair-value losses.
-
Group earnings depended on AGICL execution and PGIPL's equity-accounted profit.
The proposed AGICL demerger, which would hand AGSL shareholders AGICL shares directly, would make AGSL more clearly a financial-services company plus an ethanol stake. CARE explicitly identifies dependence on these two non-core entities as a rating constraint.
Strategy
Stated strategic themes (reconstructed from filings)
The FY2026 annual report MD&A could not be accessed in full. Themes are taken from board outcomes, the demerger rationale and press releases.
-
"Unlock value through structural separation." The 24 August 2026 demerger rationale states that AGICL as an independent entity will gain greater focus and the ability to raise capital independently, and that the arrangement will create a more transparent corporate structure. This follows the withdrawn 2025 composite scheme to demerge broking.
-
Scale the infrastructure-advisory franchise. Management guides to 20 to 22% growth in AGICL revenue and profit in FY2027. The order book is above ₹400 cr, and H1 FY2027 inflows of ₹154 cr were more than double the prior year.
-
Green-fuel optionality. PGIPL capacity is 485 KLPD, with the Sambalpur plant ready and awaiting an OMC tender. Management positions PGIPL to benefit from E22 to E30 blending and the June 2026 excise exemption.
-
Green-tech diversification. The MECC reactor alliance with Entity 1 Value Emission (September 2025) for waste-to-value and decarbonisation at Kangra.
-
Balance-sheet strengthening and promoter support. Conversion of the ₹25 cr promoter loan to equity (July 2026), plus up to 80 lakh warrants at ₹16.58 (about ₹13.3 cr) for non-promoter investors.
-
Investor outreach. Participation in the Bharat Connect Conference "Rising Stars 2026" (30 September 2026), the first disclosed investor-meet activity in the sources reviewed.
Initiatives in the last 24 months
| Date | Initiative | Type | Target / scale |
|---|---|---|---|
| Jul 2024 | PGIPL Sambalpur 200 KLPD plant construction | Capacity expansion (associate) | ₹280 cr project cost |
| Jul 2024 | 1:6 stock split | Liquidity | Face value ₹1 |
| Aug 2024 | Almondz-Wealth Ltd formed | New business vehicle | — |
| Apr 2025 | Composite scheme (broking demerger plus group amalgamations) | Restructuring | Withdrawn; re-filing intended |
| Aug 2025 / Mar 2026 | Partial sale of AGICL stake to Almondz Finanz | Portfolio / value crystallisation | Stake 100% to 79.15% to 58.52% |
| Sep 2025 | PGIPL x Entity 1 MECC alliance | Green-tech partnership | Pilot |
| Feb to Jun 2026 | 80 lakh convertible warrants at ₹16.58 | Capital raising | About ₹13.3 cr |
| Feb to Jul 2026 | ₹25 cr loan-to-equity conversion | De-leveraging | 1.63 cr shares at ₹15.32 |
| Aug 2026 | AGICL demerger and listing | Restructuring | 666:10,000 ratio |
| Sep 2026 | Investor conference participation | IR | — |
Medium-term targets and guidance
Infrastructure advisory: 20 to 22% growth in revenue and profitability in FY2027 over FY2026 (Q1 FY2027 press release).
Group-level financial targets: Not publicly disclosed.
CARE upgrade triggers (an external benchmark): scale growth above 20% with operating margin above 15%; collection period below 90 days.
ESG / sustainability targets: Not publicly disclosed.
Products & Services
Pricing for advisory and broking services is generally not publicly disclosed. Industry-standard models are noted where relevant and are not company-specific disclosures.
Financial services (AGSL standalone, AFSL, ACPL, Almondz-Wealth)
| Offering | Description | Target customer | Pricing model | Status / notes |
|---|---|---|---|---|
| Debt capital markets (DCM) arrangement | Arranging and syndicating bonds and debentures, private placements, state/PSU borrowing | PSUs, state entities, corporates | Arrangement fee (% of issue); not disclosed | Historic core niche. Exact league-table position not publicly disclosed. |
| Equity capital markets / merchant banking | IPO/QIP/rights management, SME issues, open offers | Mid/small corporates | Success fee; not disclosed | SEBI merchant-banking registration referenced in business descriptions |
| Corporate advisory / M&A | Structuring, valuation, restructuring advisory | Corporates | Retainer plus success fee | Included in consultancy segment revenue |
| Institutional equities | Sales, trading and research for institutions | Domestic institutions | Brokerage | Scale not disclosed |
| Retail and HNI broking | Equity, derivatives, currency broking | Retail / HNI | Brokerage | Revenue falling (wealth/broking segment -36.7% in FY2026) |
| Commodity broking | Through Almondz Commodities Pvt Ltd | Traders, hedgers | Brokerage | Small (subsidiary turnover about ₹0.05 cr in FY2025) |
| Depository participant services | Demat accounts and custody | Retail | Account and transaction fees | Transfer to AFSL dropped in Dec 2023 |
| Wealth management and product distribution | Mutual funds, bonds, insurance (insurance broking subsidiary historically) | HNI, family offices | Trail/commission | Almondz-Wealth Ltd formed Aug 2024 |
| Proprietary debt and equity market operations | Treasury trading and strategic investments | Own book | P&L | ₹22.21 cr revenue in FY2026 offset by fair-value losses |
| Insolvency resolution services | Through Almondz Insolvency Resolutions Services | Creditors, IBC processes | Professional fees | Consolidated from Jun 2025 |
| NBFC / finance activities | Lending (segment revenue nil in FY2025 and FY2026) | — | Interest | Dormant at AGSL level. The group NBFC is Almondz Finanz (outside AGSL). |
Infrastructure advisory (AGICL)
| Offering | Description | Target customer | Flagship / evidence |
|---|---|---|---|
| Programme / project management consultancy (PgMC/PMC) | End-to-end programme oversight | State industrial development corporations | ₹33.15 cr Odisha IDCO PgMC award, two years (29 Sep 2026) |
| Authority's engineer / independent engineer / supervision | Construction supervision under HAM/EPC/BOT for roads and highways | NHAI, MoRTH, state PWDs (sector cited by CARE: roads, highways, bridges) | Specific contract names beyond IDCO not disclosed in sources reviewed |
| Railway consultancy | Supervision and design support for railway projects | Rail agencies | Cited by CARE as a FY2026 growth driver |
| Urban infrastructure, water and sanitation | Urban planning, WASH | Urban local bodies, missions | AGICL & AGSL WASH JV |
| Feasibility studies / DPRs | Techno-economic feasibility and detailed project reports | Government agencies, financiers | Group capability listed in the annual report summary (highways, power, airports, urban, water) |
| Financial closure and transaction advisory | Debt syndication for infrastructure projects | Concessionaires | Synergy with AGSL DCM capability |
| Risk and assurance services | Independent review and audit of projects | Lenders, authorities | Annual report business overview |
Order book: above ₹400 cr at 30 September 2026. New orders were ₹154 cr in H1 FY2027, more than double the prior-year H1 according to the company. YTD wins were ₹97.32 cr as of 28 July 2026.
Green fuel (PGIPL, associate)
| Asset / product | Capacity | Location | Status |
|---|---|---|---|
| Sansarpur plant: original line | 85 KLPD | Plot 1, Sansarpur Terrace Industrial Area Phase-III, Kangra, Himachal Pradesh | Operating; ZLD-equipped |
| Sansarpur plant: expansion line | 200 KLPD | Same site | Commercial production from Nov 2023 |
| Sambalpur plant | 200 KLPD | Sambalpur district, Odisha | Construction, installation and commissioning complete. Full-scale commercial production awaits an OMC procurement tender (company, 28 Jul 2026). ZLD-equipped. |
| Product: fuel ethanol (grain-based) | 485 KLPD total installed | — | Supplied to OMCs under the EBP Programme; PGIPL described as the largest ethanol supplier in Himachal Pradesh |
| By-products | DDGS / distillery co-products | — | Not quantified |
| MECC reactor pilot (with Entity 1 Value Emission) | Pilot | Kangra site | First reactor delivered Sep 2025 |
Source conflict: ScanX/Avonmore commentary (June 2026) states that the Sambalpur facility "has started commercial production". The company's own 28 July 2026 press release says full-scale commercial production has not begun because of the pending OMC tender. The primary source is preferred here.
Financial Narrative
Basis. Consolidated figures are in ₹ crore. FY2022 to FY2026 come from Screener/C-MOTS rounded data, cross-checked against company-reported FY2025 and FY2026 audited consolidated results.
Definitions.
-
Screener "Sales" (₹174 cr for FY2026) differs from company-reported "Revenue from operations" (₹190.43 cr) and from CARE's "Total operating income" (₹170.10 cr). The likely reason is that aggregators net fair-value losses and gains on financial instruments. Both figures are shown where material.
-
"Operating income / EBITDA" is Screener's operating profit, which excludes other income.
-
"Gross profit" is not a standard line for a financial-services business. It is approximated as revenue from operations less fee and commission expense, which mainly covers AGICL's sub-consultant and associate costs. It is shown only where company data exists.
Income statement
FY2026 company-reported PAT is ₹28.72 cr, of which ₹27.75 cr is attributable to owners. FY2025 PAT is ₹17.33 cr. The company-reported FY2025 basic EPS is ₹1.04. FY2026 basic/diluted EPS is shown in the filing as approximately ₹1.6, but the OCR of the PDF is unclear, so the Screener figure is used.
Note on "other income": Screener's "other income" line (₹16 cr in FY2026) appears to include the share of associate profit (₹16.60 cr). The company's own "Other income" line is only ₹1.19 cr. This matters for any quality-of-earnings analysis: about half of FY2026 PBT is equity-accounted ethanol profit, not operating cash income.
Margins and growth
Revenue CAGR FY2022 to FY2026 (Screener sales): about 26.0% a year (₹69 cr to ₹174 cr). Screener cites 23% for five years and 32% for three years.
Balance sheet
Short-term versus long-term debt split is not publicly disclosed in the sources reviewed. Total debt per CARE was ₹53.11 cr (FY2025) and ₹49.34 cr (FY2026). Consolidated "borrowings other than debt securities" was ₹45.40 cr at 31 Mar 2026. The ₹25 cr unsecured loan from Avonmore was converted to equity in July 2026, which should reduce reported debt materially in FY2027. CARE puts free cash and bank balances at about ₹21.19 cr on 30 June 2026. Working capital as a single figure is not publicly disclosed (Screener working-capital days: 242 in FY2026).
Cash flow
The company-reported consolidated OCF is -₹4.09 cr (FY2026) and -₹9.43 cr (FY2025). FY2026 net cash raised through borrowings and share capital was ₹26.09 cr.
Ratios
The current ratio is not publicly disclosed, because the company presents a liquidity-ordered Ind AS Schedule III Division III balance sheet without a current/non-current split. ROIC is not separately computed. ROCE is used as the proxy.
Commentary on trends, inflections and drivers
Revenue. The FY2024 inflection (+54%) coincided with AGICL scaling up infrastructure supervision work and with the post-2023 recovery in Indian capital markets. FY2025 (+28%) and FY2026 (+16% on Screener's basis, +26% on company-reported revenue from operations) were again led by AGICL. By FY2026, consultancy and advisory accounted for 81% of segment revenue. Revenue is strongly back-ended, as is usual for government consultancy: Q4 FY2026 alone delivered ₹72.19 cr, 38% of the year, because of year-end milestone certification.
Profitability. Reported net profit is lumpy and depends on non-operating items:
-
FY2024 (₹34 cr) included about ₹18 cr of Q3 FY2024 "other income", mostly associate and investment gains.
-
FY2025 halved to ₹17 cr as other income normalised and fair-value movements turned negative.
-
FY2026 recovered to ₹28.7 cr. About 58% of that came from PGIPL's equity-accounted share (₹16.60 cr), and Q4 included a capital gain from selling AGICL shares to a promoter-group company. Fair-value losses of ₹16.4 cr on the treasury book in the same quarter partly offset the gain.
Underlying operating EBITDA margin has stayed in a narrow 11 to 15% band, typical of labour-intensive consultancy.
Q1 FY2027 run-rate. Revenue from operations was ₹44.50 cr (+40.7% YoY) and PAT ₹12.53 cr (+81.6%). OPM was 22.4% against 17.9%, and the tax rate fell to about 1%. CARE reports a Q1 FY2027 PBILDT margin of 23.44%. Screener's TTM figures are revenue ₹202 cr and PAT ₹34.4 cr. Expanding margins in a seasonally weak quarter are a positive datapoint, but the abnormally low tax charge flatters PAT.
Balance sheet. Leverage is low and falling (CARE gearing 0.17x, pre-conversion). Equity has grown mainly through retained earnings and, in FY2026, through NCI created by selling AGICL shares. The rising share of investments in total assets (₹166 cr of ₹384 cr) reflects the holding-company character. The ₹25 cr loan conversion (July 2026) both de-levers the company and raises promoter ownership.
Cash flow. This is the main weakness. OCF was negative in three of the last five years, and cumulative OCF over FY2022 to FY2026 is only about ₹18 cr against cumulative reported net profit of about ₹115 cr. The causes are (i) equity-accounted profit that is non-cash and has not been upstreamed as dividends from PGIPL (dividends received from associates are not disclosed), and (ii) AGICL's long government receivables cycle. Improvement in debtor days (189 to 114 over FY2024 to FY2026) is real but has not yet produced positive OCF.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship to AGSL | Business | Notes |
|---|---|---|---|
Avonmore Capital & Management Services Ltd | Holding company (promoter) | Listed holding company | Shareholders at 30 Jun 2026: Innovative Money Matters Pvt Ltd 33.14%, Rakam Infrastructures Pvt Ltd 16.21%, Navjeet Singh Sobti 8.20% (CARE) |
Almondz Global Infra-Consultant Ltd (AGICL) | Subsidiary, 58.52% (Mar 2026) | Infrastructure advisory | Demerger and listing proposed (Aug 2026) |
Almondz Financial Services Ltd (AFSL) | Wholly owned subsidiary | Broking / DP-related services | — |
Almondz Commodities Pvt Ltd (ACPL) | Wholly owned subsidiary | Commodity broking | — |
Skiffle Advisory Services Ltd (formerly Skiffle Healthcare Services Ltd) | Wholly owned subsidiary | Advisory (formerly healthcare) | Source of the "Healthcare activities" segment |
North Square Projects Pvt Ltd | Wholly owned subsidiary | Projects / real estate holding | — |
Almondz-Wealth Ltd | Wholly owned subsidiary (from 28 Aug 2024) | Wealth management | — |
Almondz Broking Services Ltd | Wholly owned subsidiary (from 9 Apr 2025) | Intended recipient of broking demerger | Composite scheme withdrawn |
Almondz Insolvency Resolutions Services Pvt Ltd | Listed as a subsidiary in the results note (from 27 Jun 2025), as an associate in the auditor's report, and as a full subsidiary in CARE Annexure-5 | Insolvency professional services | Classification discrepancy across documents |
Premier Green Innovations Pvt Ltd (PGIPL; formerly Premier Alcobev Pvt Ltd) | Associate / JV, 40.99% (held through a wholly owned subsidiary) | Grain-based ethanol, 485 KLPD | Avonmore holds a further 8.88% |
AGICL & AGSL WASH JV | Joint venture (AOP) | Water, sanitation and hygiene consultancy | — |
Almondz Finanz Ltd | Group company (promoter group), not a subsidiary | NBFC | Bought part of AGSL's AGICL stake |
Segment Assets & Liabilities and Revenue by Segment
| Segment (INR Cr) | FY2025 | FY2026 |
|---|---|---|
Debt and equity market operations | 3.09 | 22.21 |
Consultancy and advisory fees | 127.21 | 154.72 |
Wealth advisory / broking activities | 20.29 | 12.85 |
Finance activities | 0 | 0 |
Healthcare activities | 0.08 | 0.13 |
Others | 0.45 | 0.52 |
Total revenue from operations | 151.12 | 190.43 |
Segment Assets & Liabilities and Revenue by Segment by Segment Result
| Segment result (INR Cr) | FY2025 | FY2026 |
|---|---|---|
Debt and equity market operations | -3.17 | 0.29 |
Consultancy and advisory fees | 15.85 | 21.14 |
Wealth advisory / broking activities | 2.02 | 0.87 |
Healthcare activities | -0.01 | -1.31 |
Others | 0.36 | 0.40 |
Total segment result | 14.95 | 21.39 |
Less: unallocable expenditure (net) | 3.96 | 4.94 |
PBT before share of associates | 10.99 | 16.45 |
Add: share of profit of associates/JV | 9.29 | 16.60 |
Profit before tax | 20.28 | 33.05 |
Segment Revenue
| Segment | Revenue YoY growth % | Segment margin FY2025 % | Segment margin FY2026 % | Share of FY2026 revenue % |
|---|---|---|---|---|
Debt & equity market operations | 618.8 | -102.6 | 1.3 | 11.7 |
Consultancy & advisory fees | 21.6 | 12.5 | 13.7 | 81.2 |
Wealth advisory / broking | -36.7 | 10.0 | 6.8 | 6.7 |
Healthcare | 62.5 | — | — | 0.1 |
Others | 15.6 | 80.0 | 76.9 | 0.3 |
Revenue by Segment and Revenue by Segment (%)
| Vertical metric (INR Cr) | Q1 FY2026 | Q4 FY2026 | Q1 FY2027 |
|---|---|---|---|
Financial services revenue | 9.20 | 20.80 | 17.17 |
Financial services profit | 2.52 | -0.51 | 7.69 |
Infrastructure advisory revenue | 22.43 | 51.39 | 28.53 |
Infrastructure advisory profit | 1.88 | 2.31 | 2.49 |
PGIPL revenue (100% basis) | 192.25 | 179.35 | 179.33 |
PGIPL profit (100% basis) | 10.55 | 12.15 | 11.41 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue - Screener sales (INR Cr) | 69 | 76 | 117 | 150 | 174 |
Revenue from operations - company reported (INR Cr) | — | — | — | 151.12 | 190.43 |
Total operating income - CARE (INR Cr) | — | — | — | 150.96 | 170.10 |
Gross profit proxy - revenue less fees and commission expense (INR Cr) | — | — | — | 78.07 | 105.72 |
Operating profit / EBITDA - Screener (INR Cr) | 10 | 9 | 16 | 17 | 27 |
PBILDT - CARE (INR Cr) | — | — | — | 18.23 | 23.27 |
Other income (INR Cr) | 18 | 15 | 27 | 11 | 16 |
Interest (INR Cr) | 5 | 5 | 4 | 3 | 4 |
Depreciation (INR Cr) | 2 | 2 | 3 | 4 | 6 |
Profit before tax (INR Cr) | 20 | 18 | 36 | 20 | 33 |
Net income (INR Cr) | 19 | 16 | 34 | 17 | 29 |
EPS basic - Screener split-adjusted (INR) | 1.19 | 1.02 | 2.12 | 1.01 | 1.60 |
Dividends per share (INR) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue growth - Screener sales (%) | 9.5 | 10.1 | 53.9 | 28.2 | 16.0 |
Operating (EBITDA) margin (%) | 14 | 12 | 14 | 11 | 15 |
PBILDT margin - CARE (%) | — | — | — | 12.07 | 13.68 |
PBT margin on sales (%) | 29.0 | 23.7 | 30.8 | 13.3 | 19.0 |
Net margin on sales (%) | 27.5 | 21.1 | 29.1 | 11.3 | 16.7 |
PAT margin - CARE (%) | — | — | — | 11.48 | 16.89 |
Effective tax rate (%) | 8 | 11 | 5 | 15 | 13 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 252 | 271 | 317 | 351 | 384 |
Cash and cash equivalents (INR Cr) | — | — | — | 22.05 | 6.20 |
Total borrowings (INR Cr) | 24 | 21 | 23 | 53 | 49 |
Net debt (INR Cr) | — | — | — | 31.1 | 43.2 |
Shareholders' equity excl. NCI (INR Cr) | 184 | 211 | 220 | 241 | 269 |
Non-controlling interest (INR Cr) | 0 | 0 | 0 | 0 | 24.09 |
Net worth incl. NCI - CARE (INR Cr) | — | — | — | 236.60 | 289.97 |
Goodwill and intangibles (INR Cr) | — | — | — | 4.80 | 3.57 |
Investments incl. associates (INR Cr) | 61 | 69 | 93 | 122 | 166 |
Investment in associates - equity method (INR Cr) | — | — | — | 82.35 | 97.79 |
Trade receivables (INR Cr) | — | — | — | 52.13 | 54.13 |
Fixed assets (INR Cr) | 43 | 45 | 49 | 51 | 46 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (INR Cr) | 10 | -14 | 35 | -9 | -4 |
Capex - company reported (INR Cr) | — | — | — | 5.02 | 1.97 |
Free cash flow - Screener (INR Cr) | 5 | -16 | 29 | -14 | -6 |
Investing cash flow (INR Cr) | -4 | 2 | -33 | -13 | -33 |
Financing cash flow (INR Cr) | 1 | 7 | -6 | 33 | 22 |
Dividends paid (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE - computed on average equity (%) | 10.9 | 8.1 | 15.8 | 7.4 | 11.4 |
ROA - computed on average assets (%) | 8.2 | 6.1 | 11.6 | 5.1 | 7.9 |
ROCE - Screener (%) | 13 | 10 | 10 | 9 | 12 |
Debt to equity (x) | 0.13 | 0.10 | 0.10 | 0.22 | 0.18 |
Overall gearing - CARE (x) | — | — | — | 0.22 | 0.17 |
Net debt to EBITDA (x) | — | — | — | 1.8 | 1.6 |
Interest coverage - EBITDA/interest, Screener (x) | 2.0 | 1.8 | 4.0 | 5.7 | 6.8 |
Interest coverage - PBILDT, CARE (x) | — | — | — | 5.52 | 5.20 |
TD/GCA - CARE (x) | — | — | — | 2.48 | 1.43 |
Asset turnover - sales/avg assets (x) | 0.30 | 0.29 | 0.40 | 0.45 | 0.47 |
Debtor days - Screener | 191 | 154 | 189 | 127 | 114 |
Average collection period - CARE (days) | — | — | — | 134 | 112 |
Cash conversion cycle - Screener (days) | 191 | 154 | 189 | 127 | 114 |
Revenue by Region
| Region (INR Cr, revenue from operations) | FY2025 | FY2026 |
|---|---|---|
India | 151.12 | 190.43 |
Outside India | 0 | 0 |
Busine Overview
| Business | Indicative geographic footprint | Evidence |
|---|---|---|
Infrastructure advisory (AGICL) | Pan-India government projects; Odisha newly prominent (IDCO PgMC ₹33.15 cr); northern India historically | IDCO LoA (Sep 2026); CARE |
Green fuel (PGIPL, associate; not in revenue) | Himachal Pradesh (285 KLPD) and Odisha (200 KLPD) | Company press releases |
Financial services | Delhi NCR and Mumbai | Office addresses |
Capital Markets
| Item | Value | Source / date |
|---|---|---|
Last close | ₹19.6 | Screener, 16 Oct 2026 |
52-week high / low | ₹21.9 / ₹10.7 | Screener |
Market capitalisation | About ₹374 cr | Screener |
Shares outstanding (implied) | About 19.1 cr | Market cap / price; consistent with 17.36 cr plus 1.63 cr allotted |
1-year price return | +15% | Screener |
3-year price CAGR | +10% | Screener |
5-year price CAGR | -2% | Screener (split-adjusted). Trade Brains (Feb 2026) cites +33%; sources conflict, likely different base dates. |
10-year price CAGR | +24% | Screener |
Recent reference prices | ₹14.07 (22 May 2026); ₹12.97 (22 Jul 2026); about ₹19.1 (20 Sep 2026) | MarketsMojo; MoneyWorks4Me; Pocketful |
NSE series | BE (trade-for-trade) | Screener exchange tag |
Valuation Multiples
| Multiple | AGSL | Peer reference |
|---|---|---|
P/E (TTM) | 11.0x | Emkay 39.0x (May 2026); industry about 21x (MarketsMojo, May 2026) |
P/B | 1.26x (book value ₹15.5) | — |
EV/Sales (TTM) | About 2.1x (EV about ₹417 cr: market cap ₹374 cr + debt ₹49 cr - cash ₹6 cr at FY2026; revenue TTM ₹202 cr) | — |
EV/EBITDA (TTM) | About 14.4x (TTM EBITDA ₹29 cr) | — |
Dividend yield | 0% | — |
Capital Markets (Annual)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Dividend payout (%) | 0 | 0 | 0 | 0 | 0 |
Buyback (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Share Price & Returns
| Date | Instrument | Size | Price | Allottee |
|---|---|---|---|---|
Jul 2026 | Equity (loan conversion) | 1,63,18,538 shares (₹25 cr) | ₹15.32 | Avonmore Capital (promoter) |
| — | Fully convertible warrants | Up to 80,00,000 (about ₹13.3 cr) | ₹16.58 | Non-promoter investors |
Feb 2025, Jun 2026 | ESOP 2007 allotments | Small | Exercise price not disclosed | Employees |
Credit Ratings
| Agency | Rating | Outlook | Date | History |
|---|---|---|---|---|
CARE Ratings | CARE BBB- (long-term bank facilities, ₹2.64 cr) | Stable | 8 Oct 2026 | BBB-/Stable on 6 Oct 2023, 3 Oct 2024 and 9 Oct 2025 |
Moody's / S&P / Fitch | Not rated | — | — | — |
Analyst Conclusions
Management guidance
Infrastructure advisory: revenue and profit growth of 20 to 22% in FY2027 over FY2026, with "growth trend" maintained (Q1 FY2027 press release).
Green fuel: Sambalpur commercial production to begin "immediately" once an OMC tender is won. Timing is not guided.
Group-level guidance: none.
Consensus expectations
There is no sell-side consensus. A simple run-rate check:
-
Q1 FY2027 PAT of ₹12.53 cr annualises to about ₹50 cr, but Q1 is seasonally weak for revenue, and the tax rate was abnormally low (about 1%).
-
TTM PAT is ₹34.4 cr.
-
CARE expects "improvement in turnover and profitability in the near-to-medium term".
Bull case
-
Demerger value unlock. AGICL generated about ₹155 cr of segment revenue and ₹21 cr of segment profit in FY2026 and has a ₹400 cr-plus order book. Its listing could attract an infrastructure-services multiple well above the ~11x P/E at which the whole group currently trades. AGSL shareholders would receive AGICL shares directly while AGSL keeps its residual stake.
-
Ethanol operating leverage. Sambalpur adds 200 KLPD to 285 KLPD at Sansarpur. If it wins the next OMC tender under an expanding E22 to E30 regime with excise relief, PGIPL's profit (about ₹45 cr annualised on a 100% basis from Q4 FY2026 and Q1 FY2027 run-rates) could rise materially. That would flow to AGSL's 40.99% equity-accounted share.
-
Cleaner balance sheet and promoter alignment. The ₹25 cr loan conversion takes gearing well below 0.17x. Promoters are buying in the open market, and the CARE upgrade triggers (margin above 15%, growth above 20%) are already being met on a Q1 FY2027 basis.
Bear case
-
Earnings quality and cash. Cumulative FY2022 to FY2026 OCF of about ₹18 cr against about ₹115 cr of cumulative PAT. Half of FY2026 PBT is non-cash associate income, and Q4 FY2026 included a related-party stake-sale gain. Reported EPS overstates distributable earnings.
-
Governance and dilution. AGICL stake sales went to a promoter-group NBFC ahead of the demerger. The promoter preferential issue was priced at ₹15.32 against a current ₹19.6. Repeated corrigenda and exchange observations, together with no dividend for 15 years, justify a governance discount.
-
Concentration and execution. About 80% of AGICL revenue is government-sourced and milestone-billed, so a slowdown in state capex or payment delays hits both revenue and receivables. PGIPL is tender-dependent, and its Q1 FY2027 revenue fell 6.7% YoY.
Key catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | What to watch |
|---|---|---|
| Q2 FY2027 results | Mid-Nov 2026 | Sustaining 20%+ OPM; normalised tax rate; OCF |
| NCLT filings and approval for AGICL demerger | FY2027 to FY2028 | Exchange observation letters (no repeat of the 2025 withdrawal); valuation report |
| OMC ethanol tender and Sambalpur start-up | When tendered | Allocation volume; PGIPL margins |
| AGICL order inflows | Quarterly | Book above ₹400 cr growing; new state PgMC wins |
| Warrant allotment and conversion | 18 months from allotment | Investor identity; conversion rate |
| Re-filing of broking demerger | Unconfirmed | Scope of future group simplification |
| Receivables / collection period | FY2027 annual | Movement toward CARE's 90-day upgrade trigger |
| Related-party disclosures in the FY2026 annual report | Available now | AGICL stake-sale consideration and valuation |
| Dividend policy | AGM 2027 | Any first payout since FY2011 |
Concluding analyst verdict
Almondz Global Securities is a misnamed company. Its "securities" franchise is now the smallest and weakest of its three businesses. The investment case rests on an infrastructure consultancy, AGICL, that is growing, profitable and backed by an order book of more than ₹400 crore, and on a 41% stake in a 485 KLPD ethanol producer positioned for India's move beyond E20 blending. At about ₹374 crore of market capitalisation, 11x trailing earnings and 1.3x book, the market is pricing the group as a struggling micro-cap broker. That looks inexpensive against the visible earnings power of the two non-financial assets.
The discount is not irrational, though. Three issues stand out.
Cash: Reported profits have not turned into cash. Five-year operating cash flow is a small fraction of cumulative net income, because the largest profit contributor is an equity-accounted associate that pays no disclosed dividends, and the largest revenue contributor bills government clients with collection periods above 100 days.
Governance: The governance record carries visible blemishes: related-party sales of AGICL shares to a promoter-group NBFC, a promoter allotment priced below today's market, repeated disclosure corrigenda, and fifteen years without a dividend.
Restructuring: The group's earlier restructuring attempt was withdrawn after exchange observations, so the current demerger carries real approval risk.
On balance, AGSL is a special-situation, catalyst-driven idea rather than a quality compounder. The next 12 to 18 months bring three binary events: NCLT progress on the AGICL demerger, an OMC tender for the commissioned Sambalpur plant, and evidence in the FY2027 accounts that receivables and operating cash flow are improving. If all three land, the sum-of-the-parts gap could close sharply. If any falters, the stock is likely to stay range-bound, as its -2% five-year price CAGR (Screener) suggests.
Overall stance: Speculative positive, conditional on the catalysts. Sizing should reflect micro-cap liquidity (trade-for-trade series, negligible institutional ownership) and governance risk, and position sizes should stay tight until related-party valuations and the cash-flow trend are clearer.
All figures are from public filings and sources as cited.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure / key dates | Background (as disclosed) |
|---|---|---|---|
Satish Chandra Sinha | Non-Executive Independent Chairman | Independent director since at least FY2018; Chairman by FY2021 | Independent director; detailed profile not publicly disclosed in the sources reviewed |
Manoj Kumar Arora | Managing Director (DIN 06777177) | WTD from 25 Apr 2024 (five-year term); MD from 12 Aug 2024 | Previously ran key operations of Almondz Financial Services Ltd (100% subsidiary) as its director and served as Executive Director at AGSL (BSE filing, 25 Apr 2024) |
Ajay Pratap | Director - Legal & Corporate Affairs and Company Secretary (Whole-time Director; DIN 10805775) | Company Secretary since at least FY2021; on board by FY2025 | Company secretary and compliance officer |
Rajeev Kumar | Director - Finance & CFO (Whole-time Director) | Appointed 22 May 2026 for five years from DIN allotment; shareholders approved 7/8 Jul 2026 | Chartered Accountant with more than 20 years in finance; already group CFO |
Neelu Jain | Independent Director | Non-executive director since at least FY2018; re-designated independent from 22 May 2026 to 21 May 2031 | Teaching, administration and HR background; director of Jan Sikshan Sansthan; member of the company's POSH committee |
Surinder Singh (S. S.) Kohli | Independent Director | Appointed additional independent director on 12 Aug 2024 | Former banker; filing excerpt references senior roles including CMD positions and Punjab National Bank and SIDBI leadership |
Rajkumar Khanna | Independent Director | Listed on board in 2025 | Profile not publicly disclosed in the sources reviewed |
Ajay Kumar | Independent Director (listed in 2025 board data) | Independent director since at least FY2018. | — |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
25 Apr 2024 | New WTD appointed (five years) | Elevation of a subsidiary executive |
12 Aug 2024 | Manoj Kumar Arora becomes MD; N. S. Sobti steps off the board to become Senior Executive Director | Generational and professional management transition; also coincides with internal auditor resignation |
12 Aug 2024 | S. S. Kohli appointed independent director | Banking expertise added |
22 May 2026 | Rajeev Kumar becomes Director-Finance & CFO; Neelu Jain re-designated independent | Board strengthening ahead of demerger and capital raising |
May 2026 | An independent director's tenure ends | Vacancy noted by ScanX |
Shareholding Trend
| Holder category | Mar 2024 % | Mar 2025 % | Mar 2026 % | Jun 2026 % | Sep 2026 % |
|---|---|---|---|---|---|
Promoters (mainly Avonmore Capital) | 58.19 | 51.29 | 51.18 | 50.82 | 56.06 |
FIIs | 1.59 | 1.27 | 0.02 | 0.00 | 0.08 |
DIIs | 0.00 | 0.00 | 0.12 | 0.37 | 0.28 |
Public | 40.19 | 47.43 | 48.67 | 48.81 | 43.57 |
Number of shareholders | 7,501 | 13,712 | 15,484 | 15,271 | 15,771 |
Competitive Landscape
Competitors by Segment
| Vertical | Competitor | Listed? | Relative positioning vs AGSL |
|---|---|---|---|
Broking / investment banking | Emkay Global Financial Services | Yes (NSE/BSE) | Larger institutional franchise; P/E 39.0x and ROE 11.83% versus AGSL's 8.4x and 8.63% in May 2026 (MarketsMojo) |
Broking / investment banking | Monarch Networth Capital | Yes | Larger retail and IB franchise |
Broking / investment banking | Arihant Capital Markets | Yes | Comparable small-cap broker |
Broking / investment banking | Inventure Growth & Securities | Yes | Comparable small-cap broker |
Broking / investment banking | Choice International | Yes | Diversified broker with government-advisory arm; direct overlap with infrastructure consulting |
Broking / investment banking | Discount brokers (Zerodha, Groww, Angel One) | Mixed | Structural pressure on retail broking yields |
Debt arranging | Trust Investment Advisors, A. K. Capital Services, JM Financial | Mixed | Established DCM franchises |
Infrastructure advisory | RITES Ltd | Yes (PSU) | Much larger; government-backed |
Infrastructure advisory | Intercontinental Consultants & Technocrats (ICT) | No | Major highway supervision peer |
Infrastructure advisory | LEA Associates South Asia | No | Highway and urban consultancy peer |
Infrastructure advisory | Theme Engineering Services | No | Authority's engineer peer |
Infrastructure advisory | Feedback Infra | No | PMC / transaction advisory |
Ethanol (PGIPL) | Balrampur Chini, Triveni Engineering, Shree Renuka, Gulshan Polyols, India Glycols | Yes | Larger integrated sugar or grain distillers |
Peer Comparison FY2026
| Metric | AGSL | Emkay Global Financial |
|---|---|---|
FY2026 revenue (INR Cr) | 190.4 (company revenue from operations) | — |
Revenue growth FY2026 (%) | 26.0 (company basis) / 16.0 (Screener) | — |
Operating margin FY2026 (%) | 15 | — |
ROE (%) | 11.4 (FY2026 computed) | 11.83 (MarketsMojo, May 2026) |
P/E (x) | 11.0 (Oct 2026) | 39.0 (May 2026) |
Recent Developments
*Q2 Historically they are announced mid-November.



